Improving Risk Stratification to Guide Treatment Decisions for Children, Adolescents, and Young Adults With Hodgkin Lymphoma

Author: Lianna J. Marks MD
View More View Less
Restricted access

Disclosures: Dr. Marks has disclosed receiving no financial considerations from any person or organization to support the preparation, analysis, results, or discussion of this article.

Correspondence: Lianna J. Marks, MD, Stanford University School of Medicine, 1000 Welch Road, Suite 300, Stanford, CA 94304. Email: marksl@stanford.edu

View associated content

  • 1.

    Flerlage JE, Kelly KM, Beishuizen A, et al. Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): methodology statement. Pediatr Blood Cancer 2017;64:e26421.

    • Search Google Scholar
    • Export Citation
  • 2.

    Henderson TO, Parsons SK, Wroblewski KE, et al. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: an adult intergroup (E2496) and Children’s Oncology Group (COG AHOD0031) comparative analysis. Cancer 2018;124:136144.

    • Search Google Scholar
    • Export Citation
  • 3.

    Foltz LM, Song KW, Connors JM. Hodgkin’s lymphoma in adolescents. J Clin Oncol 2006;24:25202526.

  • 4.

    Giulino-Roth L, Pei Q, Buxton A, et al. Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group. Blood 2021;137:14491456.

    • Search Google Scholar
    • Export Citation
  • 5.

    Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 1998;339:15061514.

    • Search Google Scholar
    • Export Citation
  • 6.

    Schwartz CL, Chen L, McCarten K, et al. Childhood Hodgkin International Prognostic Score (CHIPS) predicts event-free survival in Hodgkin lymphoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2017;64:e26278.

    • Search Google Scholar
    • Export Citation
  • 7.

    Mottok A, Johnston RL, Chun Chan F, et al. Prediction of primary treatment outcome using gene expression profiling of pre-treatment biopsies obtained from childhood and adolescent Hodgkin lymphoma patients. Blood 2015;126:175.

    • Search Google Scholar
    • Export Citation
  • 8.

    Johnson P, Federico M, Kirkwood A, et al. Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma. N Engl J Med 2016;374:24192429.

    • Search Google Scholar
    • Export Citation
  • 9.

    Bhakta N, Liu Q, Yeo F, et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin’s lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol 2016;17:13251334.

    • Search Google Scholar
    • Export Citation
  • 10.

    Oeffinger KC, Stratton KL, Hudson MM, et al. Impact of risk-adapted therapy for pediatric Hodgkin lymphoma on risk of long-term morbidity: a report from the Childhood Cancer Survivor Study [published online February 25, 2021]. J Clin Oncol, doi: https://doi.org/10.1200/JCO.20.01186

    • Search Google Scholar
    • Export Citation
  • 11.

    Parsons SK, Kelly MJ, Cohen JT, et al. Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes. Br J Haematol 2018;182:212221.

    • Search Google Scholar
    • Export Citation
  • 12.

    Rodday AM, Parsons SK, Scharman C, et al. Prognostication for advanced stage Hodgkin lymphoma (HL) in the modern era: a project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium. Blood 2020;136(Suppl 1):1618.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1022 1022 1019
PDF Downloads 668 668 666
EPUB Downloads 0 0 0